Repatha vs Skyrizi
Side-by-side drug price comparison from Medicare Part D data
Verdict
Repatha costs 83% less per claim than Skyrizi ($757.00 vs $4475.00). Neither drug has a generic alternative available. Total Medicare spending: Repatha at $2.6B vs Skyrizi at $2.3B.
| Metric | Repatha | Skyrizi |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $757* | $4,475 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $2.6B | $2.3B |
| Total Claims | 3,420,000 | 524,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 24.6%* | 42.8% |
| Generic Available | No | No |
| Condition | High Cholesterol | Autoimmune Diseases |
| Total Beneficiaries | 398,000 | 78,000 |
Repatha costs 83% less per claim than Skyrizi ($757.00 vs $4475.00). Neither drug has a generic alternative available. Total Medicare spending: Repatha at $2.6B vs Skyrizi at $2.3B.